| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/08/2013 | CA2585359C Gaba-steroid antagonists and their use for the treatment of cns disorders |
| 01/08/2013 | CA2566155C 1-aza-bicyclo[3.3.1]nonanes |
| 01/08/2013 | CA2558764C New association between agomelatine and a thymoregulator and the pharmaceutical compositions that contain it |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2492930C Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 01/03/2013 | WO2013003298A2 Inhibitors of pde10 |
| 01/03/2013 | WO2013002420A1 Method for producing fine particles of aripiprazole anhydride crystals b |
| 01/03/2013 | WO2013002404A1 Method for alleviating fear memory |
| 01/03/2013 | WO2013002364A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001819A1 SOLUBLE INTEGRIN α4 MUTANT |
| 01/03/2013 | WO2013001509A1 Composition comprising the association of melissa officinalis extract, methylamide and non- coding nucleic acid chains, and the use thereof in the treatment of cephalalgias and migraine |
| 01/03/2013 | WO2013001498A1 Amidoalkylpiperazinyl derivatives for the treatment of central nervous system diseases |
| 01/03/2013 | WO2013001490A1 Novel anti-inflammatory dihydrochalcone derivatives and use thereof |
| 01/03/2013 | WO2013001412A1 Compositions for the treatment of fragile x syndrome |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | WO2013000974A1 Methods for treating immune-mediated diseases of the nervous system administering a compound comprising agents that inhibit prokineticin receptors activity |
| 01/03/2013 | WO2013000924A1 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
| 01/03/2013 | WO2013000895A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | WO2013000651A1 Fluorinated arylalkylaminocarboxamide derivatives |
| 01/03/2013 | WO2013000399A1 Substituted cinnamamide derivative, preparation method and use thereof |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | WO2013000392A1 Aripiprazole type i microcrystal, aripiprazole solid preparation, and preparation method |
| 01/03/2013 | WO2013000391A1 Aripiprazole medicament formulation and preparation method therefor |
| 01/03/2013 | WO2012149472A9 Methods, compositions, and kits for treating and preventing neurological conditions |
| 01/03/2013 | WO2012149335A3 Small molecule inhibitors of rgs proteins |
| 01/03/2013 | WO2012149024A3 Dna aptamers for promoting remyelination |
| 01/03/2013 | WO2012136356A8 6,7-diydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation |
| 01/03/2013 | WO2012128576A3 Composition for treating lower or damaged cognitive function containing dehydroglyasperin c typically found in licorice |
| 01/03/2013 | WO2012112953A3 Molecular switch for neuronal outgrowth |
| 01/03/2013 | WO2012107735A3 Treatment of bipolar disorder |
| 01/03/2013 | WO2012098546A3 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
| 01/03/2013 | US20130006351 Polymer coatings containing drug powder of controlled morphology |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005821 Intravenous administration of tramadol |
| 01/03/2013 | US20130005820 Agomelatine hydrochloride hydrate and preparation thereof |
| 01/03/2013 | US20130005816 Transdermal compositions of ibuprofen and methods of use thereof |
| 01/03/2013 | US20130005806 Analysis of tmlhe and carnitine biosynthesis for autism diagnosis |
| 01/03/2013 | US20130005801 Phenylcarbamate compound and muscle relaxant containing the same |
| 01/03/2013 | US20130005800 Composition for transdermal or transmucosal administration |
| 01/03/2013 | US20130005789 Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes |
| 01/03/2013 | US20130005786 Therapeutic invention |
| 01/03/2013 | US20130005784 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/03/2013 | US20130005783 Prevention And Treatment Of Diseases Caused By Elevated Levels Of Deoxy-Sphingolipids |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005770 Organic compounds |
| 01/03/2013 | US20130005762 Combination of droloxifene and clopidogrel |
| 01/03/2013 | US20130005755 Peripherally Acting Opioid Compounds |
| 01/03/2013 | US20130005744 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/03/2013 | US20130005743 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/03/2013 | US20130005740 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 01/03/2013 | US20130005732 New medical use of triazine derivatives |
| 01/03/2013 | US20130005731 Crystalline forms of neurotrophin mimetic compounds and their salts |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005721 Indolizine inhibitors of 5-lipoxygenase |
| 01/03/2013 | US20130005717 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 01/03/2013 | US20130005713 Process for Preparing Diaminophenothiazinium Compounds |
| 01/03/2013 | US20130005710 Aminopyridine derivative |
| 01/03/2013 | US20130005709 Sulfone compounds as 5-ht6 receptor ligands |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005706 Fused heterocyclic compounds as ion channel modulators |
| 01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | US20130005703 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-ht6 receptor |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130005694 Liquid compositions comprising vitamin d and uses thereof |
| 01/03/2013 | US20130005693 Method for Reducing Levels of Disease Associated Proteins |
| 01/03/2013 | US20130005689 Compounds for the treatment of addiction |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/03/2013 | US20130005679 Multivitamin Compositions and Methods for Improving Health |
| 01/03/2013 | US20130005676 Enhancing the therapeutic effect of acupuncture with adenosine |
| 01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |
| 01/03/2013 | US20130005666 Reporter system for high throughput screening of compounds and uses thereof |
| 01/03/2013 | US20130005662 Methods of Treating Depression and Other Related Diseases |
| 01/03/2013 | US20130005655 Combination therapy using low-dose doxepin for the improvement of sleep |
| 01/03/2013 | US20130005651 Death associated protein 1 variants and use thereof for modulating autophagy |
| 01/03/2013 | US20130005650 Methods and compositions for treating diseases associated with pathogenic proteins |
| 01/03/2013 | US20130005646 Polypeptides |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130005644 Cyclic agonists and antagonists of c5a receptors and g protein-coupled receptors |
| 01/03/2013 | US20130005608 Yeast screens for treatment of human disease |
| 01/03/2013 | US20130004977 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/03/2013 | US20130004651 Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials |
| 01/03/2013 | US20130004604 Dark chocolate delivery system for a combination of dietary supplements and pharmaceuticals |
| 01/03/2013 | US20130004599 Formulation for transdermal delivery to promote sleep |
| 01/03/2013 | US20130004583 Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use |
| 01/03/2013 | US20130004575 Controlled release formulations using intelligent polymers |
| 01/03/2013 | US20130004574 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointensinal tract |
| 01/03/2013 | US20130004572 Stable pharmaceutical composition and methods of using same |
| 01/03/2013 | US20130004571 Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product |
| 01/03/2013 | US20130004563 Multiparticulate s-adenosylmethionine compositions and related methods |
| 01/03/2013 | US20130004545 Slow release pharmaceutical compositions of iloperidone |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004517 Disc-1 pathway activators in the control of neurogenesis |